PIN Pharma is a clinical stage venture backed immunotherapy company focused on the development of PINS (precision immune stimulants). The Company’s technology is predicated upon modulating the innate immune response to overcome cancer-mediated immune suppression. Pin Pharma is pursuing immune oncology as its first indication albeit PINS have potential in other therapeutic areas.
